Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome
- PMID: 4357902
Item in Clipboard
Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome
Helv Med Acta.
1973 Oct.
No abstract available
Similar articles
-
Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.Lancet. 1974 Mar 9;1(7854):385-89. doi: 10.1016/s0140-6736(74)93150-x. Lancet. 1974. PMID: 4131034 No abstract available.
-
[Short term treatment of Paget's disease with porcine calcitonin].Rev Rhum Mal Osteoartic. 1973 Oct;40(10):557-63. Rev Rhum Mal Osteoartic. 1973. PMID: 4797550 French. No abstract available.
-
Fractional intestinal absorption and retention of calcium measured by whole-body counting. Application of a power function model.Scand J Clin Lab Invest. 1975 May;35(3):197-203. Scand J Clin Lab Invest. 1975. PMID: 807965
-
[Methods of estimation of vitamin D supply in humans].Vopr Pitan. 1981 Sep-Oct;(5):3-8. Vopr Pitan. 1981. PMID: 7032070 Review. Russian. No abstract available.
-
Adrenocorticotropic hormone-independent Cushing's syndrome.Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):219-25. doi: 10.1097/MED.0b013e32814db842. Curr Opin Endocrinol Diabetes Obes. 2007. PMID: 17940443 Review.
Cited by
-
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.Calcif Tissue Int. 1984 May;36(3):245-52. doi: 10.1007/BF02405325. Calcif Tissue Int. 1984. PMID: 6432287
-
Salmon calcitonin in the therapy of corticoid-induced osteoporosis.Eur J Clin Pharmacol. 1987;33(1):35-9. doi: 10.1007/BF00610377. Eur J Clin Pharmacol. 1987. PMID: 3319638 Clinical Trial.
-
Serum levels of calcitonin in Cushing's syndrome.J Endocrinol Invest. 1986 Jun;9(3):239-41. doi: 10.1007/BF03348108. J Endocrinol Invest. 1986. PMID: 3760462
-
25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man.J Endocrinol Invest. 1984 Oct;7(5):445-8. doi: 10.1007/BF03348448. J Endocrinol Invest. 1984. PMID: 6239890